Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

68,383 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial.
Cheng Y, Chen J, Zhang W, Xie C, Hu Q, Zhou N, Huang C, Wei S, Sun H, Li X, Yu Y, Lai J, Yang H, Fang H, Chen H, Zhang P, Gu K, Wang Q, Shi J, Yi T, Xu X, Ye X, Wang D, Xie C, Liu C, Zheng Y, Lin D, Zhuang W, Lu P, Yu G, Li J, Gu Y, Li B, Wu R, Jiang O, Wang Z, Wu G, Lin H, Zhong D, Xu Y, Shu Y, Wu D, Chen X, Wang J, Wang M, Yang R. Cheng Y, et al. Among authors: wang z, wang j, wang m, wang d, wang q. Nat Med. 2024 Oct;30(10):2967-2976. doi: 10.1038/s41591-024-03132-1. Epub 2024 Jul 11. Nat Med. 2024. PMID: 38992123 Free PMC article. Clinical Trial.
The miR-599 promotes non-small cell lung cancer cell invasion via SATB2.
Tian W, Wang G, Liu Y, Huang Z, Zhang C, Ning K, Yu C, Shen Y, Wang M, Li Y, Wang Y, Zhang B, Zhao Y. Tian W, et al. Among authors: wang g, wang y, wang m. Biochem Biophys Res Commun. 2017 Mar 25;485(1):35-40. doi: 10.1016/j.bbrc.2017.02.005. Epub 2017 Feb 4. Biochem Biophys Res Commun. 2017. Retraction in: Biochem Biophys Res Commun. 2019 Aug 6;515(4):733. doi: 10.1016/j.bbrc.2018.11.193 PMID: 28167280 Retracted.
Retraction notice to "The miR-599 promotes non-small cell lung cancer cell invasion via SATB2" [Biochem. Biophys. Res. Commun. 485/1 (2017) 35-40].
Tian W, Wang G, Liu Y, Huang Z, Zhang C, Ning K, Yu C, Shen Y, Wang M, Li Y, Wang Y, Zhang BC, Zhao Y. Tian W, et al. Among authors: wang g, wang y, wang m. Biochem Biophys Res Commun. 2019 Aug 6;515(4):733. doi: 10.1016/j.bbrc.2018.11.193. Biochem Biophys Res Commun. 2019. PMID: 31239038 No abstract available.
Integrative Proteomic Characterization of Human Lung Adenocarcinoma.
Xu JY, Zhang C, Wang X, Zhai L, Ma Y, Mao Y, Qian K, Sun C, Liu Z, Jiang S, Wang M, Feng L, Zhao L, Liu P, Wang B, Zhao X, Xie H, Yang X, Zhao L, Chang Y, Jia J, Wang X, Zhang Y, Wang Y, Yang Y, Wu Z, Yang L, Liu B, Zhao T, Ren S, Sun A, Zhao Y, Ying W, Wang F, Wang G, Zhang Y, Cheng S, Qin J, Qian X, Wang Y, Li J, He F, Xiao T, Tan M. Xu JY, et al. Among authors: wang x, wang g, wang f, wang y, wang m, wang b. Cell. 2020 Jul 9;182(1):245-261.e17. doi: 10.1016/j.cell.2020.05.043. Cell. 2020. PMID: 32649877 Free article.
68,383 results
You have reached the last available page of results. Please see the User Guide for more information.